GAITHERSBURG, Md., March 2 /PRNewswire-FirstCall/ -- Iomai Corporation today announced that Stanley C. Erck, the company’s president and chief executive officer, is scheduled to present at the SG Cowen & Co. 26th Annual Healthcare Conference on Monday March 6, 2006 at 4:50 p.m. EST. The conference will be held at the Boston Marriott Copley Place from Monday, March 6 through Thursday, March 9, 2006.
To access the live audio webcast or the subsequent archived recording, log on to the Investor Relations section on the Overview page of the Iomai website at www.iomai.com. Please connect to Iomai’s website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.
About Iomai Corporation
Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). Iomai leverages TCI to enhance the efficacy of existing vaccines, develop new vaccines that are viable only through transcutaneous administration and expand the global vaccine market by reducing the amount of vaccine needed to stimulate an immune response. Iomai currently has four product candidates in development: three targeting influenza and pandemic flu and one to prevent E. coli-related travelers’ diarrhea. For more information on Iomai, please visit www.iomai.com.
Iomai Corporation
CONTACT: Russell P. Wilson, Senior Vice President, Chief Financial Officerand General Counsel, of Iomai Corporation, +1-301-556-4478, orinvestors@iomai.com; or Daryl Messinger of WeissComm Partners, Inc.,+1-415-999-2361, or daryl@weisscommpartners.com, for Iomai Corporation
Web site: http://www.iomai.com//
